Radiosensitization of human vascular endothelial cells through Hsp90 inhibition with 17-N-allilamino-17-demethoxygeldanamycin.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2008.02.034PMID 18410996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Hsp90: A Multitarget Approach to Radiosensitization

  2007cited by this paper
• Vascular damaging agents.

  2007cited by this paper
• Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.

  2006cited by this paper
• Hsf1-Mediated Stress Response can Transiently Enhance Cellular Radioresistance

  2006cited by this paper
• Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis

  2006cited by this paper
• Integrin αvβ3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non–small-cell lung cancer models

  2006cited by this paper
• P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines.

  2006cited by this paper
• Emerging Hsp90 inhibitors: from discovery to clinic.

  2006cited by this paper
• In vitro combined modality treatment of prostate carcinoma cells with 17-(allylamino)-17-demethoxygeldanamycin and ionizing radiation.

  2006cited by this paper
• Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy.

  2006cited by this paper
• Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.

  2006cited by this paper
• VEGF-subtype specific protection of SCC and HUVECs from radiation induced cell death.

  2005cited by this paper
• Combined inhibition of extracellular signal-regulated kinases and HSP90 sensitizes human colon carcinoma cells to ionizing radiation

  2005cited by this paper
• Heat shock protein 90 inhibitor 17‐allylamino‐17‐demethoxygeldanamycin potentiates the radiation response of tumor cells grown as monolayer cultures and spheroids by inducing apoptosis

  2005cited by this paper
• Differential Activation of the Phosphatidylinositol 3′-Kinase/Akt Survival Pathway by Ionizing Radiation in Tumor and Primary Endothelial Cells

  2004cited by this paper
• p38 MAPK Mediates γ-Irradiation-induced Endothelial Cell Apoptosis, and Vascular Endothelial Growth Factor Protects Endothelial Cells through the Phosphoinositide 3-Kinase-Akt-Bcl-2 Pathway*

  2004cited by this paper
• Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin

  2004cited by this paper
• Pharmacological attenuation of apoptosis in reoxygenated endothelial cells

  2004cited by this paper
• Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin

  2004cited by this paper
• Basic Fibroblast Growth Factor Inhibits Radiation-Induced Apoptosis of HUVECs. I. The PI3K/AKT Pathway and Induction of Phosphorylation of BAD

  2004cited by this paper
• Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization.

  2003cited by this paper
• A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

  2003cited by this paper
• Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.

  2003cited by this paper
• Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response.

  2003cited by this paper
• Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis

  2003cited by this paper
• Overexpression of the Cochaperone CHIP Enhances Hsp70-Dependent Folding Activity in Mammalian Cells

  2003cited by this paper
• Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids.

  2003cited by this paper
• Hsp90 inhibitors as novel cancer chemotherapeutic agents.

  2002cited by this paper
• Vascular Endothelial Growth Factor Enhances Endothelial Cell Survival and Tumor Radioresistance

  2002cited by this paper
• Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation.

  2002cited by this paper
• New pathway for nuclear entry of HIV-1

  2002cited by this paper
• Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice

  2001cited by this paper
• New agents in cancer clinical trials

  2000cited by this paper
• Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency.

  2000cited by this paper
• Thermostability of a nuclear-targeted luciferase expressed in mammalian cells. Destabilizing influence of the intranuclear microenvironment.

  1995cited by this paper
• Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo.

  1994cited by this paper

• Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922

  2019cites this paper
• Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer

  2019cites this paper
• Triolimus: A Multi-Drug Loaded Polymeric Micelle Containing Paclitaxel, 17-AAG, and Rapamycin as a Novel Radiosensitizer.

  2017cites this paper
• Induction of Hsp70 in tumor cells treated with inhibitors of the Hsp90 activity: A predictive marker and promising target for radiosensitization

  2017cites this paper
• The effect of heat shock factor 1 (HSF-1) and heat shock proteins Hsp70 and Hsp27 on radiosensitivity and immunogenicity

  2016cites this paper
• Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity.

  2015cites this paper
• Mechanisms for SU5416 as a radiosensitizer of endothelial cells.

  2015cites this paper
• Examination of Gossypol-Pluronic Micelles as Potential Radiosensitizers

  2015cites this paper
• Current concepts in clinical radiation oncology

  2013cites this paper
• Modulation of radiosensitivity of human tumor and normal cells by inhibition of heat shock proteins Hsp90 and Hsp70

  2013cites this paper
• The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin modulates radiosensitivity by downregulating serine/threonine kinase 38 via Sp1 inhibition.

  2013cites this paper
• Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia

  2012cites this paper
• The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage

  2012cites this paper
• Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity.

  2012cites this paper
• Molecular Pathways: Targeting Hsp90—Who Benefits and Who Does Not

  2012cites this paper
• Thermosensitization of tumor cells with inhibitors of chaperone activity and expression

  2012cites this paper
• Jekyll and Hyde: the role of the microenvironment on the progression of cancer

  2011cites this paper
• Inhibitors of heat shock protein 90 activity: A novel class of tumor radiosensitizers

  2011cites this paper
• Hsp90 inhibitors as promising agents for radiotherapy

  2010cites this paper
• Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction

  2010cites this paper
• Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls

  2010cites this paper
• Heat Shock Protein 90 as a Drug Target: Some Like It Hot

  2009cites this paper
• Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy

  2009cites this paper